Rockwell Medical Technologies, Inc.

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Nov 30, 2021TrialTreatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy

Apr 19, 2021TrialTriferic AVNU Infusion Via Freedom Pump During Hemodialysis

Sep 1, 2020TrialHemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)

Jun 25, 2020TrialStudy to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.

Mar 27, 2020FDATriferic — TRIFERIC AVNU

Sep 30, 2019TrialA Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients

Oct 1, 2017TrialEquivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients

Jan 17, 2017TrialTriferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol

1 more events

Jan 1, 2017TrialStudy of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

2 patent groups across drugs · Source: FDA Orange Book

DrugExpires

TrifericSep 8, 2027 TrifericApr 17, 2029

Regulatory

Regulatory Timeline

20151 event

FDAJan 23

Triferic — TRIFERIC

Application NDA206317 (NDA)

20161 event

FDAApr 25

Triferic — TRIFERIC

Application NDA208551 (NDA)

20201 event

FDAMar 27

Triferic — TRIFERIC AVNU

Application NDA212860 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)